🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Major depressive disorder (MDD) is a significant public health problem and ...
Status
Not Yet Recruiting
Location
Cohen and Associates
Start Date
2026-09-01
Trial ID
NCT07227103
Treatments Being Tested
The purpose of this Expanded Access Treatment Protocol is to make NRX-101 a...
Status
Available
Location
Harvard Mclean Hospital
Start Date
TBD
Trial ID
NCT05779267
Treatments Being Tested
NMDA antagonist drugs have increasingly been demonstrated to reduce symptom...
Status
Unknown
Location
Research Site, Birmingham
Start Date
2019-12-01
Trial ID
NCT03396068
Treatments Being Tested
Subnormal level of Glutamate+Glutamine (Glx) in the Anterior Cingulate Cort...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2018-11-01
Trial ID
NCT03402152
Treatments Being Tested
The goal of this clinical study is to test NRX101 in participants with comp...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03-31
Trial ID
NCT06128213
Treatments Being Tested
NeuroRx is developing NRX-101, a fixed-dose combination oral capsule compos...
Status
Completed
Location
Research Site, Birmingham
Start Date
2018-01-15
Trial ID
NCT02974010
NMDA antagonist drugs have shown to reduce symptoms of depression and suici...
Status
Completed
Location
Science 37
Start Date
2022-05-12
Trial ID
NCT03395392
Treatments Being Tested